Drugs for pre-osteoporosis: prevention or disease mongering? Journal Articles

abstract

• After looking at data used to support treatment of women with slightly lowered bone mineral density, Pablo Alonso-Coello and colleagues argue thatproponents have overstated the benefits and underplayed the harms

authors

• Alonso-Coello, Pablo
• García-Franco, Alberto López
• Guyatt, Gordon
• Moynihan, Ray

status

• published 

publication date

• January 19, 2008

has subject area

• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)
• Bone Density Conservation Agents (MeSH)
• Conflict of Interest (MeSH)
• Female (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Marketing of Health Services (MeSH)
• Meta-Analysis as Topic (MeSH)
• Osteoporosis (MeSH)
• Risk Assessment (MeSH)
• Risk Factors (MeSH)

published in

• The BMJ  Journal

keywords

• Bone Density Conservation Agents
• Conflict of Interest
• Female
• Humans
• Marketing of Health Services
• Meta-Analysis as Topic
• Osteoporosis
• Risk Assessment
• Risk Factors

Digital Object Identifier (DOI)

• 10.1136/bmj.39435.656250.ad

start page

• 126

end page

• 129

volume

• 336

issue

• 7636